Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · August 12, 2024

Impact of GLP-1 RAs on Cardiorenal Outcomes and Mortality in People With Type 2 Diabetes and Acute Kidney Disease

Nature Communications

 

Additional Info

Nature Communications
GLP-1 receptor agonists' impact on cardio-renal outcomes and mortality in T2D with acute kidney disease
Nat Commun 2024 Jul 13;15(1)5912, HC Pan, JY Chen, HY Chen, FY Yeh, CY Sun, TT Huang, VC Wu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading